The Current Ratio as of September 2024 (TTM) for Moderna, Inc. (MRNA) is 4.09

According to Moderna, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.09. This represents a change of 16.74% compared to the average of 3.50 of the last 4 quarters.

Moderna, Inc. (MRNA) Historical Current Ratio (quarterly & annually)

How has MRNA Current Ratio performed in the past?

The mean historical Current Ratio of Moderna, Inc. over the last ten years is 4.52. The current 4.09 Current Ratio has changed 8.95% with respect to the historical average. Over the past ten years (40 quarters), MRNA's Current Ratio was at its highest in in the June 2020 quarter at 17.30. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Moderna, Inc. (MRNA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Moderna, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Moderna, Inc. (MRNA) Average Current Ratio

How has MRNA Current Ratio performed in the past?

The current Current Ratio of Moderna, Inc. (MRNA) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Moderna, Inc. (MRNA) Current Ratio vs. Peers

How is MRNA’s Current Ratio compared to its peers?

Moderna, Inc.’s Current Ratio is greater than CureVac N.V. (2.29), greater than Novavax, Inc. (1.04), less than CohBar, Inc. (4.16), greater than Reata Pharmaceuticals, Inc. (3.21), less than Ocean Biomedical, Inc. (0), greater than Enveric Biosciences, Inc. (0.03), less than Hepion Pharmaceuticals, Inc. (7.37), less than Elevation Oncology, Inc. (5.62), less than AVROBIO, Inc. (41.10), less than Rain Therapeutics Inc. (26.17), less than Krystal Biotech, Inc. (5.58), less than Intellia Therapeutics, Inc. (9.50), less than Editas Medicine, Inc. (7.21), greater than Vertex Pharmaceuticals Incorporated (3.85), greater than Beam Therapeutics Inc. (2.52), less than Ginkgo Bioworks Holdings, Inc. (5.81), less than null (4.71),

Build a custom stock screener for Moderna, Inc. (MRNA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Moderna, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Moderna, Inc. (MRNA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Moderna, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.